Helix BioPharma Corp. (HBP.TO)

CAD 1.0

(5.26%)

Annual Income Statements

(In CAD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - - - -
Cost of Revenue 14 Thousand 13 Thousand 12 Thousand 173 Thousand 212 Thousand 56 Thousand
Gross Profit -14 Thousand -13 Thousand -12 Thousand -173 Thousand -212 Thousand -56 Thousand
Operating Expenses 9.35 Million 6.32 Million 6.04 Million 9.13 Million 8.61 Million 7.49 Million
Selling, General and Administrative Expenses 3.26 Million 299 Thousand 595 Thousand 3.24 Million 2.71 Million 2.46 Million
Research and Development Expenses 6.09 Million 5.28 Million 4.54 Million 5.88 Million 5.86 Million 5 Million
Other Expenses - -59 Thousand 901 Thousand 3000.00 29 Thousand 17 Thousand
Cost and Expenses 9.37 Million 6.32 Million 6.04 Million 9.13 Million 8.61 Million 7.49 Million
Operating Income -9.37 Million -6.27 Million -6.53 Million -9.61 Million -8.59 Million -7.48 Million
Interest Expense 7000.00 14 Thousand 18 Thousand 15 Thousand 25 Thousand 1000.00
Income Tax Expense -132 Thousand 14 Thousand -484 Thousand -1.66 Million 449 Thousand 1000.00
Earnings before Tax -9.39 Million -6.29 Million -6.56 Million -9.57 Million -8.56 Million -7.52 Million
Net Income -9.26 Million -6.29 Million -6.08 Million -7.91 Million -9.01 Million -7.52 Million
Earnings Per Share Basic -0.21 -0.16 -0.20 -0.29 -0.35 -0.35
Earnings Per Share Diluted -0.21 -0.16 -0.20 -0.29 -0.35 -0.35
Weighted Average Shares Outstanding 44.48 Million 38.64 Million 29.89 Million 27.57 Million 25.54 Million 21.32 Million
Weighted Average Shares Outstanding (Diluted) 44.48 Million 38.64 Million 29.89 Million 27.57 Million 25.54 Million 21.32 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -9.38 Million -6.31 Million -6.02 Million -9.46 Million -8.44 Million -6.71 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts